Delivery Order SPE2DB25D3012-SPE2DB25FXAEB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,385.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 15, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order contains no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,126.10. The order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its Corporate Office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,259.24 firm fixed-price delivery order for Valtoco 10 mg nasal sprays on September 28, 2025, with completion scheduled for September 29, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,354.30 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The contract, issued on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee and will perform work at its corporate office location. This delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency has awarded a delivery order totaling $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. This contract is not set-aside and was competitively awarded to the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 3, 2025. This firm fixed-price contract, awarded on September 2, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Valtoco is a naloxone nasal spray formulation used for...
- The Defense Logistics Agency awarded a delivery order valued at $3,106.66 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of September 15, 2025. This competitive award (no set-aside used) represents a firm fixed-price delivery order executed on September 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a naloxone nasal spray used for emergency treatment of opioid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays under a firm fixed price contract valued at $2,187.24. The award, issued on November 17, 2025, represents a non-competitive delivery order with an ultimate completion date of November 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valtoco 5 mg nasal spray, with a ceiling value of $2,252.20 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAEBDelivery Order
The Defense Logistics Agency awarded a $2,208.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 20 mg nasal sprays. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a discrete transaction under the company's broader federal pharmaceutical supply portfolio. This award is a child contract issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to military healthcare programs worldwide. Valtoco (naloxone) is a critical emergency medication used to reverse opioid overdoses, supporting the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's position as a primary pharmaceutical distributor for federal medical procurement demonstrates its capability to fulfill specialized medical supply requirements through competitive federal contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/17/25 |